Literature DB >> 9806634

Peptide antagonism and T cell receptor interactions with peptide-MHC complexes.

Y Sykulev1, Y Vugmeyster, A Brunmark, H L Ploegh, H N Eisen.   

Abstract

We describe antagonist peptides that specifically inhibit cytolytic activity of T cell clones and lines that express the antigen-specific receptor of CD8+ T lymphocyte clone 2C, which recognizes peptides in association with syngeneic (Kb) and allogeneic (Ld) MHC proteins. Addition of an antagonist peptide that can bind to Kb on 2C cells decreased the tyrosine phosphorylation of CD3 zeta chains elicited by prior exposure of the cells to an agonist peptide-Kb complex. Contrary to previous agonist-antagonist comparisons, the 2C T cell receptor had higher affinity for an antagonist peptide-Kb complex than for a weak agonist peptide-Kb complex. This difference is considered in light of evidence that antigen-specific receptor affinity values can be substantially higher when determined with the receptor on live cells than with the receptor in cell-free systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806634     DOI: 10.1016/s1074-7613(00)80631-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  35 in total

1.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

Authors:  P D Holler; P O Holman; E V Shusta; S O'Herrin; K D Wittrup; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor.

Authors:  B K Cho; K C Lian; P Lee; A Brunmark; C McKinley; J Chen; D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.

Authors:  V Rubio-Godoy; V Dutoit; D Rimoldi; D Lienard; F Lejeune; D Speiser; P Guillaume; J C Cerottini; P Romero; D Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Cooperative enhancement of specificity in a lattice of T cell receptors.

Authors:  C Chan; A J George; J Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules.

Authors:  Eckart Schott; Nicolas Bertho; Qing Ge; Madelon M Maurice; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

6.  Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.

Authors:  Qing Ge; Jennifer D Stone; M Todd Thompson; Jennifer R Cochran; Mia Rushe; Herman N Eisen; Jianzhu Chen; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

7.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

8.  Clustering class I MHC modulates sensitivity of T cell recognition.

Authors:  David R Fooksman; Gigi Kwik Grönvall; Qing Tang; Michael Edidin
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

Review 9.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

10.  Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.

Authors:  Christos Tsatsanis; Katerina Vaporidi; Vassiliki Zacharioudaki; Ariadne Androulidaki; Yuri Sykulev; Andrew N Margioris; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.